Prohibits healthcare professionals in South Carolina from administering synthetic mRNA-based gene therapies, except for certain exceptions.
The bill prohibits healthcare professionals in South Carolina from administering synthetic mRNA-based gene therapies, citing concerns about adverse events, contamination, and lack of long-term studies. Exceptions include treatments for noninfectious diseases, traditional live attenuated vaccines, FDA-authorized recombinant bacterial or viral vaccines, and FDA-authorized genetic therapies not using synthetic mRNA-based technology. Violations result in a one-year suspension of the healthcare professional's license, with additional penalties at the board's discretion.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.